now offering semaglutide Type 2 diabetes: New Ozempic pill available in the U.S Semaglutide Weight Loss | Face

usually mild-to-moderate and easing with time [2] [4]

Williamson 2021)

Ozempic is a brand-name medication that contains semaglutide as its active ingredient

(AACE 2023 Obesity Guidelines, endocrine.org) The Obesity Society's position statement notes: "Pharmacotherapy for obesity should be considered an adjunct to, not a replacement for, behavioral intervention, and should be maintained long-term in patients who respond." This language directly supports Michigan Medicaid PA criteria requiring concurrent behavioral program participation

Retatrutide: Triple Agonist Still in Development Retatrutide activates three hormone pathways at once: GLP-1, GIP, and glucagon